Complete financial analysis of Consonance-HFW Acquisition Corp. (CHFW-UN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Consonance-HFW Acquisition Corp., a leading company in the industry within the sector.
- Decibel Therapeutics, Inc. (DBTX) Income Statement Analysis – Financial Results
- Xi’an Tourism Co., Ltd. (000610.SZ) Income Statement Analysis – Financial Results
- E J Holdings Inc. (2153.T) Income Statement Analysis – Financial Results
- LG Display Co., Ltd. (LPL) Income Statement Analysis – Financial Results
- Tingyi (Cayman Islands) Holding Corp. (TYCMY) Income Statement Analysis – Financial Results
Consonance-HFW Acquisition Corp. (CHFW-UN)
About Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences industry. The company was founded in 2020 and is based in Princeton, New Jersey. Consonance-HFW Acquisition Corp. is a subsidiary of Consonance Life Sciences.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 12.50M | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 27.23M | 3.27M | 3.30M | 2.93M | 0.00 |
Gross Profit | -27.23M | 9.23M | -3.30M | -2.93M | 0.00 |
Gross Profit Ratio | 0.00% | 73.85% | 0.00% | 0.00% | 0.00% |
Research & Development | 27.23M | 37.01M | 40.18M | 25.68M | 19.60M |
General & Administrative | 15.80M | 19.83M | 14.21M | 7.12M | 5.50M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 15.80M | 19.83M | 14.21M | 7.12M | 5.50M |
Other Expenses | -24.48M | 7.55M | -329.00K | 0.00 | 0.00 |
Operating Expenses | 18.55M | 56.84M | 54.39M | 32.81M | 24.81M |
Cost & Expenses | 45.78M | 56.84M | 54.39M | 32.81M | 24.81M |
Interest Income | 2.34M | 781.00K | 72.00K | 91.00K | 444.00K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.91M | 3.27M | 3.30M | 2.93M | 2.28M |
EBITDA | -41.13M | -42.38M | -51.35M | -31.37M | -22.82M |
EBITDA Ratio | 0.00% | -354.71% | 0.00% | 0.00% | 0.00% |
Operating Income | -45.78M | -44.34M | -54.39M | -32.81M | -25.11M |
Operating Income Ratio | 0.00% | -354.71% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 2.74M | 8.34M | -257.00K | 91.00K | 744.00K |
Income Before Tax | -43.04M | -36.00M | -54.65M | -32.72M | -24.36M |
Income Before Tax Ratio | 0.00% | -288.03% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -8.34M | -2.14M | -91.00K | 0.00 |
Net Income | -43.04M | -27.67M | -52.51M | -32.63M | -24.36M |
Net Income Ratio | 0.00% | -221.35% | 0.00% | 0.00% | 0.00% |
EPS | -21.33 | -11.95 | -22.48 | -41.01 | -61.94 |
EPS Diluted | -21.33 | -11.95 | -22.48 | -41.01 | -61.94 |
Weighted Avg Shares Out | 2.02M | 2.31M | 2.34M | 795.60K | 393.31K |
Weighted Avg Shares Out (Dil) | 2.02M | 2.31M | 2.34M | 795.60K | 393.31K |
Source: https://incomestatements.info
Category: Stock Reports